Ophthalmic Toxicities in BEACON Triplet Therapy for BRAF V600E-Mutant Colorectal Cancer: A Case Series.

J Anus Rectum Colon · 2025 · PMC12574812 · PMID 41180804

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Although exploratory analyses did not demonstrate a significant overall survival benefit of triplet therapy over doublet therapy, the triplet therapy regimen showed a trend toward higher objective response rates and greater tumor shrinkage.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.